Does CD34+ cell selection enrich malignant stem cells in B cell (and other) malignancies?
Reading
C L
CL
D015703:Antigens, CD; D018952:Antigens, CD34; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D015415:Biomarkers; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015448:Leukemia, B-Cell / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy*; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy; D010641:Phenotype
D015703:Antigens, CD; D018952:Antigens, CD34; D015415:Biomarkers